Bulletin
Investor Alert

Marinus Pharmaceuticals Inc.

NAS: MRNS

GO
/marketstate/country/us

After Hours

/zigman2/quotes/208112000/composite

$

6.71

Change

-0.35 -4.96%

Volume

Volume 365

Sep 23, 2022, 7:04 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/208112000/composite

Previous close

$ 6.81

$ 7.06

Change

+0.25 +3.67%

Day low

Day high

$6.24

$7.07

Open
Open: 6.70

52 week low

52 week high

$3.97

$13.15

Open

Market cap

$262.63M

Average volume

205,337

P/E ratio

N/A

Rev. per Employee

$244,336

EPS

-2.89

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/mrns

MarketWatch News on MRNS

  1. Moderna's stock drops 6.3% to pace the S&P 500's premarket losers

    10:24 a.m. Jan. 24, 2022

    - Tomi Kilgore

  2. Marinus Pharmaceuticals initiated at buy with $35 price target at Truist Securities

    8:22 a.m. Sept. 30, 2020

    - Tonya Garcia

  3. Marinus Pharmaceuticals started at outperform with $6 stock price target at Oppenheimer

    8:31 a.m. Dec. 20, 2019

    - Tomi Kilgore

  4. Marinus Pharma stock price target cut to $6 from $7 at Leerink

    8:59 a.m. Dec. 12, 2019

    - Ciara Linnane

  5. Marinus Pharma reiterated as outperform at Leerink

    2:22 p.m. Dec. 9, 2019

    - Ciara Linnane

  6. 5 stocks trading at under $10 worth discovering

    12:46 p.m. June 27, 2019

    - Michael Brush

  7. Harry Boxer’s four health-care stocks to watch

    12:54 p.m. July 12, 2018

    - Harry Boxer

  8. Bain Makes Bank in Two Rebounding Biotechs

    8:58 a.m. Dec. 21, 2017

    - Barron's Online

  9. Marinus Pharma stock surges on positive mid-stage data for rare genetic disorder drug

    11:41 a.m. Jan. 23, 2017

    - Emma Court

  10. Marinus Pharma stock surges 45% to $1.69 per share

    11:39 a.m. Jan. 23, 2017

    - Emma Court

  11. Marinus Pharmaceuticals stock price target cut to $2 from $14 at RBC Capital

    7:42 a.m. June 14, 2016

    - Tomi Kilgore

  12. Marinus Pharmaceuticals downgraded to sector perform from market perform at RBC Capital

    7:42 a.m. June 14, 2016

    - Tomi Kilgore

  13. Marinus Pharmaceuticals shares down 58% in premarket trade

    8:03 a.m. June 13, 2016

    - Ciara Linnane

  14. Marinus Pharma says to discontinue program

    7:37 a.m. June 13, 2016

    - Ciara Linnane

  15. Marinus Pharma shares halted in premarket trade

    7:37 a.m. June 13, 2016

    - Ciara Linnane

  16. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/mrns

Other News on MRNS

  1. Marinus Pharmaceuticals: Positive News Flow Of Note

    5:03 p.m. Sept. 22, 2022

    - Seeking Alpha

  2. 10-Q: MARINUS PHARMACEUTICALS, INC.

    4:07 p.m. Aug. 11, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  3. Marinus Pharmaceuticals Q2 2022 Earnings Preview

    1:49 p.m. Aug. 10, 2022

    - Seeking Alpha

  4. Notable earnings before Thursday's open

    10:45 a.m. Aug. 10, 2022

    - Seeking Alpha

  5. Assertio (ASRT) Q2 Earnings and Revenues Top Estimates

    8:25 a.m. Aug. 8, 2022

    - Zacks.com

  6. Marinus (MRNS) to Sell Rare Disease PRV to Novo Nordisk

    11:43 a.m. July 15, 2022

    - Zacks.com

  7. Notable earnings after Thursday's close

    5:35 p.m. May 11, 2022

    - Seeking Alpha

  8. Marinus Pharmaceuticals Q1 2022 Earnings Preview

    5:35 p.m. May 11, 2022

    - Seeking Alpha

  9. Loading more headlines...
/news/pressrelease/company/us/mrns

Press Releases on MRNS

  1. Marinus Pharmaceuticals to Present at Upcoming Investor Conferences

    7:30 a.m. Sept. 7, 2022

    - BusinessWire - BZX

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.